Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
8°
Light Snow
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fulcrum Therapeutics Inc
(NQ:
FULC
)
3.880
+0.030 (+0.78%)
Streaming Delayed Price
Updated: 11:53 AM EST, Dec 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Fulcrum Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
Expert Ratings For Fulcrum Therapeutics
November 14, 2024
Via
Benzinga
Earnings Scheduled For November 13, 2024
November 13, 2024
Via
Benzinga
Earnings Preview: Fulcrum Therapeutics
November 12, 2024
Via
Benzinga
Fulcrum Therapeutics's Earnings Outlook
November 12, 2024
Via
Benzinga
Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up
October 18, 2024
The company is working on treatments for forms of muscular dystrophy, and is taking on some of the biggest names in pharma.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Intraday Session
September 26, 2024
Via
Benzinga
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.
September 26, 2024
Pfizer stock dipped Thursday after the company voluntarily pulled its sickle cell drug, Oxbryta, from the market following patient deaths.
Via
Investor's Business Daily
Breaking Down Fulcrum Therapeutics: 7 Analysts Share Their Views
September 13, 2024
Via
Benzinga
Deep Dive Into Fulcrum Therapeutics Stock: Analyst Perspectives (4 Ratings)
May 13, 2024
Via
Benzinga
Deep Dive Into Fulcrum Therapeutics Stock: Analyst Perspectives (4 Ratings)
February 28, 2024
Via
Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, Sept. 14
September 14, 2024
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Sept. 9-13, 2024.
Via
Talk Markets
Dow Surges Over 100 Points; ModivCare Shares Plummet
September 12, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Crude Oil Surges 3%; Kroger Posts Upbeat Earnings
September 12, 2024
Via
Benzinga
Exposures
Fossil Fuels
Fulcrum Therapeutics Suspends Rare Muscular Disease Candidate After Disappointing Data From Pivotal Trial
September 12, 2024
Fulcrum Therapeutics stock drops after Phase 3 REACH trial of losmapimod flops in Facioscapulohumeral Muscular Dystrophy. The company consider suspending the program.
Via
Benzinga
US Stocks Mixed; Producer Prices Increase In August
September 12, 2024
Via
Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via
Benzinga
Earnings Preview: Fulcrum Therapeutics
February 26, 2024
Via
Benzinga
Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease
September 09, 2024
BofA Securities upgraded Fulcrum Therapeutics ahead of its phase 3 losmapimod results for Facioscapulohumeral muscular dystrophy, boosting the price target from $5 to $10 due to increased confidence in...
Via
Benzinga
8 Health Care Stocks With Whale Alerts In Today's Session
August 01, 2024
Via
Benzinga
Top 3 Health Care Stocks That Should Keep You Up At Night This Quarter
July 16, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
June 11, 2024
Via
Benzinga
FULC Stock Earnings: Fulcrum Therapeutics Beats EPS for Q1 2024
May 13, 2024
FULC stock results show that Fulcrum Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 13, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
May 13, 2024
It's time to start the trading week with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!
Via
InvestorPlace
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
April 15, 2024
With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
March 29, 2024
Via
Benzinga
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 06, 2024
Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.
Via
Benzinga
Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday
March 06, 2024
U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
MicroMarvet - Fulcrum Therapeutics - Confusing Projections And Recommendation
January 09, 2024
Revenue is estimated to be down 63.40% this year and down another 19.80% next year. Earnings are projected to increase 32.80% this year but be down 9.80% next year.
Via
Talk Markets
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 22, 2023
Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.